What Type of Doctor Treats Thyroid Nodules?

Several types of doctors may be involved in evaluating and treating thyroid nodules, and the specific specialist you see depends on where you are in the diagnostic process and what the nodule turns out to be. Most thyroid nodules are first noticed by a primary care physician, often as an incidental finding during imaging done for an unrelated reason. From there, the path typically runs through endocrinologists, radiologists, and pathologists for diagnosis, and potentially through surgeons, nuclear medicine doctors, or oncologists if treatment is needed. Understanding which doctor handles which part of this process can save you time and reduce the anxiety that comes with an uncertain diagnosis.

Your Primary Care Doctor Is Usually the Starting Point

For most people, the thyroid nodule journey begins with a primary care physician or internist. A nodule might turn up during a routine neck exam, or it may be spotted accidentally on a CT scan, carotid ultrasound, or other imaging study ordered for something else entirely. Most thyroid nodules are discovered this way, as incidental findings rather than because a patient noticed a lump.¹

Your primary care doctor’s first job is deciding whether the nodule warrants further investigation. Not every nodule does. Further workup is generally indicated if you have symptoms like difficulty swallowing or a visible lump, a family history of thyroid cancer, or an abnormal thyroid-stimulating hormone (TSH) level.¹ The standard first step is a blood test for TSH. In surveys of primary care physicians and internal medicine residents, virtually all report ordering TSH as part of their initial evaluation.² If the TSH is low, suggesting the thyroid is overactive, a nuclear medicine scan may be the next step. If it is normal or elevated, a thyroid ultrasound is usually ordered, and at this point an endocrinologist or radiologist typically enters the picture.

Endocrinologists Take the Lead on Thyroid Management

An endocrinologist is a physician who specializes in hormone-related conditions, including thyroid disease. For many patients with thyroid nodules, the endocrinologist becomes the central coordinator of care. They interpret ultrasound findings, decide whether a biopsy is needed, manage thyroid hormone levels, and help you weigh options if surgery or other treatment comes up.

One of the endocrinologist’s key roles is risk stratification. Thyroid nodules are extremely common, and the vast majority are benign. Risk stratification systems based on ultrasound features help identify which nodules need a biopsy and which can simply be monitored.³ The endocrinologist uses these classifications, along with your clinical history, to guide next steps. If a biopsy result comes back indeterminate, the endocrinologist may order molecular testing to refine the cancer risk estimate, since roughly one in five biopsied nodules lands in this gray zone.⁴

If you have a confirmed benign nodule, your endocrinologist will typically set up a monitoring schedule with periodic ultrasounds. If the nodule is cancerous or highly suspicious, the endocrinologist will refer you to a surgeon and often continue managing your care afterward, particularly your thyroid hormone replacement if part or all of the gland is removed.

Radiologists and the Imaging That Drives Decisions

Radiologists play a behind-the-scenes role that shapes almost every decision made about your nodule. A radiologist performs and interprets the thyroid ultrasound, applying a standardized scoring system to assess whether a nodule looks worrisome. The most widely used system in the United States is ACR TI-RADS (Thyroid Imaging Reporting and Data System), released by the American College of Radiology in 2017. It assigns points based on ultrasound features like the nodule’s shape, echogenicity, margins, and whether it contains calcifications. The resulting score translates into a management recommendation, ranging from “no biopsy needed” to “biopsy recommended.”⁵

One of the explicit goals of TI-RADS is to reduce unnecessary biopsies and, by extension, the overdiagnosis of low-risk thyroid cancers that might never cause harm.⁵ Radiologists with expertise in thyroid imaging are also the ones who typically perform the fine-needle aspiration biopsy itself, using ultrasound guidance to place the needle precisely into the nodule.⁶ In some practices, endocrinologists or surgeons perform biopsies instead, but ultrasound-guided aspiration by a radiologist is common.

Pathologists Read the Biopsy

You will probably never meet your pathologist face to face, but this doctor’s analysis of your biopsy sample is often the single most consequential step in your workup. After a fine-needle aspiration, the cells collected from your nodule go to a cytopathologist, a physician who specializes in examining individual cells under a microscope. Fine-needle aspiration cytology is the initial screening test for thyroid nodules.⁷

The pathologist classifies the biopsy result using a standardized six-category system called the Bethesda System for Reporting Thyroid Cytopathology. Each category corresponds to a different estimated risk of cancer and a different recommended next step. Category I means the sample was insufficient and may need to be repeated. Category II is benign. Categories III and IV are the “indeterminate” zone that often prompts molecular testing or a repeat biopsy. Categories V and VI indicate suspicion or confirmation of malignancy, leading to surgical referral.⁸ Pathologists sometimes review slides with colleagues to reach consensus on difficult cases, and certain institutions have multiple pathologists independently examine each sample.⁹

Surgeons Who Operate on the Thyroid

If your nodule turns out to be cancerous, highly suspicious, or large enough to cause compressive symptoms like trouble swallowing or breathing, surgery becomes part of the conversation. Several types of surgeons perform thyroidectomy (partial or total removal of the thyroid gland), and which one you see can depend on your hospital and region.

Endocrine surgeons: These are general surgeons who have completed additional fellowship training in operations on the thyroid, parathyroid, and adrenal glands. They tend to have the highest volume of thyroid cases, and surgical volume is one of the best predictors of good outcomes in thyroid surgery.
Otolaryngologists (ENT surgeons): Head and neck surgeons also perform a substantial share of thyroid operations. Clinical guidelines on improving voice outcomes after thyroid surgery have been published specifically by the otolaryngology community, reflecting how central thyroid procedures are to their practice.¹⁰
General surgeons: In communities without a dedicated endocrine surgeon or ENT specialist, a general surgeon with thyroid experience may perform the procedure.

Thyroidectomy can be performed for a range of clinical reasons beyond confirmed cancer, including benign nodules or cysts, suspicious biopsy findings, difficulty swallowing from esophageal compression, and breathing problems from airway compression.¹⁰ If you are facing surgery, asking your surgeon about their annual thyroid case volume is a reasonable and widely recommended step.

Interventional Radiologists and Nonsurgical Treatment

A newer player in thyroid nodule treatment is the interventional radiologist. These physicians specialize in minimally invasive, image-guided procedures. For thyroid nodules, interventional radiology has grown rapidly as an alternative to surgery for certain benign nodules that are causing symptoms or cosmetic concern but do not require the gland to be removed.

Interventional radiological techniques for thyroid nodules include aspiration of fluid-filled cysts, thermal ablation (using radiofrequency, laser, or microwave energy to shrink solid nodules), and ethanol injection for cystic nodules. These procedures are performed under ultrasound guidance and usually on an outpatient basis with local anesthesia. Beyond treatment, interventional radiologists also contribute to diagnosis through fine-needle aspiration and core needle biopsy.¹¹ Thermal ablation has become particularly popular in Europe and Asia, and its availability in North America is growing. It is typically reserved for nodules that are confirmed benign on two separate biopsies, so it is not a substitute for a proper diagnostic workup.

Nuclear Medicine Doctors and Radioactive Iodine

Nuclear medicine physicians use radioactive substances for both diagnosis and treatment. In the thyroid nodule context, they show up at two points. First, if your TSH is low and hyperthyroidism is suspected, a nuclear medicine doctor can perform a thyroid uptake and scan using a small dose of radioactive iodine or technetium. This test reveals whether a nodule is “hot” (producing excess hormone) or “cold” (not functional), which changes the cancer risk assessment and treatment approach. Hot nodules are almost always benign.

Second, after thyroid cancer surgery, nuclear medicine physicians administer radioactive iodine therapy to destroy any remaining thyroid tissue or cancer cells. This treatment is standard for many differentiated thyroid cancers. For nodules causing hyperthyroidism (toxic nodular goiter), radioactive iodine can also be used as a primary treatment without surgery.¹²

When an Oncologist Gets Involved

Most thyroid cancers are treated successfully with surgery and radioactive iodine, and many patients never need to see an oncologist. But a small percentage of thyroid cancers are aggressive, recurrent, or stop responding to radioactive iodine, a situation known as radioiodine-refractory disease. This is when a medical oncologist, specifically one with experience in endocrine cancers, enters the picture.

For patients with radioiodine-refractory differentiated thyroid cancer, treatment decisions hinge on whether the disease is progressing or remains stable. Slow-growing cases can sometimes be managed with active surveillance alone, while progressive or symptomatic disease requires systemic therapy. First-line options include targeted drugs called multikinase inhibitors, with cabozantinib recently approved for cases that resist initial treatment.¹³ The oncologist works closely with the rest of the thyroid team to time these therapies appropriately, since starting too early or too late both carry risks.

Thyroid Nodules in Children and During Pregnancy

Two populations deserve special mention because the approach differs from standard adult care.

In children and adolescents, thyroid nodules are less common than in adults, but when they do occur, they carry a higher risk of being cancerous. The risk of malignancy in indeterminate nodules is also higher in pediatric patients compared to adults.¹⁴ Pediatric endocrinologists generally lead the evaluation, and the ultrasound risk-stratification systems developed for adults have been adapted for younger patients, though their accuracy in children is still being studied.⁶ A pediatric surgeon or pediatric otolaryngologist handles any necessary surgery.

During pregnancy, thyroid nodule management becomes more conservative. Radioactive iodine scans and treatment are off limits because of the risk to the fetus. Ultrasound and fine-needle aspiration remain safe and are the primary diagnostic tools. If a nodule is found to be cancerous during pregnancy, the decision about when to operate depends on the cancer type and how far the pregnancy has progressed. Most low-risk cancers can be monitored until after delivery, while aggressive cancers may require surgery during the second trimester. The care team typically includes an obstetrician, an endocrinologist, and a surgeon working together.

The Multidisciplinary Tumor Board

For complex or borderline cases, especially those involving confirmed or suspected thyroid cancer, many hospitals convene a multidisciplinary tumor board. This is a meeting where endocrinologists, surgeons, radiologists, pathologists, oncologists, and sometimes radiation oncologists review a patient’s case together and reach a consensus recommendation. These boards are not a separate type of doctor, but they represent an important step in the care process.

Research on endocrine tumor boards shows they lead to a change in the management plan for roughly 15% of cases presented. The most common change is a recommendation for additional imaging. Cases involving cancer recurrence are more likely to result in a modified plan than initial presentations.¹⁵ If you are diagnosed with thyroid cancer at a major medical center, there is a good chance your case will be discussed at one of these meetings, even if you are not present for it.

Delays in the Diagnostic Pipeline

One frustration many patients experience is how long the process takes from nodule discovery to a definitive answer. A study tracking the clinical pathway for thyroid nodular disease found that the median diagnostic delay was about 60 days, and the biggest bottleneck was the wait for the thyroid ultrasound performed by the radiology department.¹⁶ Treatment timing after biopsy also varied depending on the Bethesda category. Patients with clearly suspicious or malignant results (Bethesda V or VI) tended to get to surgery on schedule, while those with benign or indeterminate results faced longer delays to their next step.¹⁶

If you feel stuck in the waiting game, it helps to know that most thyroid nodules, including the majority of thyroid cancers, are slow-growing. A delay of weeks to a couple of months, while stressful, rarely changes the clinical outcome. That said, being proactive about scheduling and following up on referrals can shave unnecessary time off the process.

The Anxiety That Comes With a Thyroid Nodule

Something that rarely gets discussed in clinical literature but matters enormously to patients is the psychological weight of having a thyroid nodule. Even when a nodule is confirmed benign, the experience of waiting for biopsy results and the awareness that you have a “lump” in your neck can trigger real anxiety. Research confirms that patients with recently diagnosed benign thyroid nodules experience heightened anxiety specifically around the possibility of cancer.¹⁷

Interestingly, the type of support that helps most is informational rather than emotional. Providing patients with clear, factual information about their condition and the diagnostic process reduces cancer-related fear more effectively than emotional reassurance alone. Offering this information before biopsy appears to be particularly beneficial.¹⁷ Patients who do receive a malignancy diagnosis show higher levels of psychological distress and sleep disruption than those with benign results, which is unsurprising but underscores the importance of mental health support throughout the process.¹⁸

Active Surveillance as an Alternative to Immediate Action

Not every thyroid nodule, and not even every thyroid cancer, needs to be treated right away. Active surveillance, meaning regular ultrasound monitoring without immediate biopsy or surgery, is increasingly recognized as a reasonable approach in certain situations. For very small suspicious nodules under one centimeter, the question of whether to biopsy immediately or watch and wait has been studied from a cost-effectiveness standpoint, with modeling suggesting that surveillance can be a viable alternative to immediate fine-needle aspiration for high-suspicion subcentimeter nodules.¹⁹

Active surveillance is also being applied to small, low-risk papillary thyroid cancers, particularly in patients who are older or have other health conditions that make surgery riskier. In these cases, the endocrinologist remains the lead physician, performing periodic ultrasounds and stepping in with treatment only if the nodule grows or changes. The shift toward less aggressive management reflects the understanding that many small thyroid cancers grow so slowly that they may never cause problems during a patient’s lifetime. Updated clinical guidelines have incorporated this more conservative approach, and modeling studies suggest the revised guidelines perform comparably to earlier, more aggressive versions in terms of quality-adjusted outcomes.²⁰

The decision about whether active surveillance is right for you is one to make with your endocrinologist, taking into account the nodule’s size, ultrasound characteristics, biopsy result, your age, your comfort with monitoring, and whether the uncertainty of watching and waiting feels manageable or intolerable. There is no single right answer, and the best care teams present it as a genuine choice rather than a default.

1
PubMed Central. Thyroid Nodules: Diagnosis and Treatment in Primary Care
2
PubMed Central. Initial evaluation of thyroid nodules by primary care physicians and internal medicine residents
3
PubMed Central. Thyroid nodules: need for a universal risk stratification system
4
JAMA Oncology. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial
5
PubMed. Update on ACR TI-RADS: Successes, Challenges, and Future Directions, From the AJR Special Series on Radiology Reporting and Data Systems
6
PubMed. Diagnostic performance of ACR-TIRADS for thyroid nodule risk stratification in pediatric patients
7
PubMed Central. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature
8
PubMed Central. The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
9
PubMed Central. The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up
10
PubMed. Clinical practice guideline: improving voice outcomes after thyroid surgery
11
PubMed Central. Current role of interventional radiology in thyroid nodules
12
PubMed Central. Outcome of radioactive iodine therapy in Toxic Nodular Goiter in Pakistan
13
PubMed Central. Systemic Therapeutic Options in Radioiodine-Refractory Differentiated Thyroid Cancer: Current Indications and Optimal Timing
14
The Journal of Clinical Endocrinology & Metabolism. Approach to the Pediatric Patient With Thyroid Nodules
15
PubMed Central. Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making
16
PubMed Central. Evaluation of a Clinical Pathway for Thyroid Nodular Disease: Timings and Delays in the Diagnosis and Treatment of Thyroid Cancer
17
PubMed. Thyroid Cancer-Related Fear & Anxiety in Patients With Benign Thyroid Nodules: A Mixed-Methods Study
18
The Journal of Clinical Endocrinology & Metabolism. Psychological Distress and Sleep Disturbance Throughout Thyroid Nodule Screening, Diagnosis, and Treatment
19
PubMed. High-Suspicion Subcentimeter Thyroid Nodules: Cost Effectiveness of Active Surveillance versus Fine Needle Aspiration
20
PubMed. Is Less More? A Microsimulation Model Comparing Cost-effectiveness of the Revised American Thyroid Association’s 2015 to 2009 Guidelines for the Management of Patients With Thyroid Nodules and Differentiated Thyroid Cancer